Colorectal Cancer

 

SIR-Sphere + FOLFOX for Liver Metastases from Colorectal Cancer (UW10025)
Randomised Comparative Study Of Folfox6m Plus SIR-Spheres® Microspheres Versus Folfox6m Alone As First Line Treatment In Patients With Nonresectable Liver Metastases From Primary Colorectal Carcinoma

Investigator: Andrew Coveler, MD;   Conditions: Colorectal Cancer, Colorectal Carcinoma, Liver Metastases;    Status: Recruiting;   Study ID: NCT00724503

Chemotherapy or Chemotherapy + Radiation for Rectal Cancer Patients Undergoing Surgery
A Phase II/III Trial of Neoadjuvant FOLFOX, With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision

Investigator: Alessandro Fichera, MD;   Conditions: Colorectal Cancer;    Status: Recruiting;   Study ID: NCT01515787